We are live on
!
Find out more
DC
Defender Capital Portfolio holdings
AUM
$308M
1-Year Est. Return
4.52%
This Fund
S&P 500
This Quarter
Est. Return
+8.24%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$50.6M
(+22%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
10.55%
Top 10 Holdings %
Top 10 Hldgs %
86.06%
Holding
39
New
9
Increased
18
Reduced
7
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$8.97M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$7.58M |
| 3 |
Costco
COST
|
+$7.53M |
| 4 |
Fortive
FTV
|
+$5.3M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$4.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$12.4M |
| 2 |
Monster Beverage
MNST
|
+$3.86M |
| 3 |
Invesco AI and Next Gen Software ETF
IGPT
|
+$967K |
| 4 |
Apple
AAPL
|
+$394K |
| 5 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
+$136K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.62% |
| 2 | Technology | 14.04% |
| 3 | Consumer Staples | 13.77% |
| 4 | Financials | 11.78% |
| 5 | Industrials | 4.52% |
Similar funds
PC
AWA
AC
EWM
ICP
ACM
GE
BBWA
Defender Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Defender Capital held 39 positions worth $280M, up 22% from $230M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Defender Capital deployed $29.6M of net new capital in Q1 2021, opening 9 new positions and adding to 18 existing holdings. Its largest new stake was Insight Molecular Diagnostics: 30,223 shares worth $3.12M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was STAAR Surgical, an estimated $12.4M trimmed.
- Defender Capital's largest Q1 2021 buy was Insight Molecular Diagnostics: 30,223 shares worth $3.12M.
- Defender Capital added most to Danaher in Q1 2021, an estimated $8.97M increase.
- Defender Capital's biggest Q1 2021 reduction was STAAR Surgical, cutting an estimated $12.4M.
- Defender Capital fully exited Fitbit, Inc. Class A common stock in Q1 2021, selling an estimated $136K.
- Defender Capital's ten largest holdings make up 86% of its $280M portfolio in Q1 2021.
- Defender Capital opened 9 new positions and closed 1 in Q1 2021.
- Defender Capital's portfolio value rose 22% quarter-over-quarter to $280M.
Based on Defender Capital's 13F filing for Q1 2021, filed 20 Apr 2021.